首页|非小细胞肺癌脑转移高危因素分析

非小细胞肺癌脑转移高危因素分析

扫码查看
目的 分析影响非小细胞肺癌(NSCLC)脑转移的高危因素。方法 回顾性分析2020-2024年福建医科大学肿瘤临床医学院/福建省肿瘤医院/复旦大学附属肿瘤医院福建医院收治的258例NSCLC患者的性别、年龄等临床及病理类型、分子病理信息,结合采用的治疗方式,综合分析影响NSCLC脑转移的高危因素。结果 (1)年轻、女性患者,EGFR突变及ALK基因重排NSCLC患者,脑转移发生率上升。(2)年轻NSCLC患者出现脑膜转移的风险较高,EGFR突变NSCLC患者出现脑膜转移的风险显著增加。(3)针对NSCLC脑转移患者,在靶向治疗的基础上,配合脑部放疗、抗肿瘤血管生成及免疫治疗;而如果患者出现脑膜转移,在靶向治疗的基础进行抗肿瘤血管生成治疗。结论 NSCLC脑转移的高危因素包括年轻、女性、EGFR突变及合并ALK重排突变。通过早期识别和干预这些高危因素,有助于提高NSCLC脑转移患者的生存率和生活质量。
Analysis of high-risk factors for brain metastasis in non-small cell lung cancer
Objective To analyze the high-risk factors of brain metastasis in non-small cell lung cancer(NSCLC).Methods A retrospective analysis was conducted on 258 NSCLC patients admitted to Clinical On-cology School of Fujian Medical University/Fujian Cancer Hospital/Fudan University Affiliated Cancer Hos-pital Fujian Hospital,including their gender,age,clinical and pathological types,molecular pathological infor-mation,and combined with the treatment methods used,to comprehensively analyze the high-risk factors of brain metastasis of NSCLC.Results(1)The incidence of brain metastasis increased in the young and female patients,as well as the non-small cell patients with EGFR mutations and ALK gene rearrangements.(2)The young NSCLC patients had a higher risk of meningeal metastasis,while the EGFR mutated NSCLC patients had a significantly increased risk of meningeal metastasis.(3)For the NSCLC patients with brain metastases,targeted therapy was combined with brain radiation therapy,anti-tumor angiogenesis,and immunotherapy;if the patient developed meningeal metastasis,anti-tumor angiogenesis therapy should be performed on the basis of targeted therapy.Conclusion High-risk factors for brain metastasis in NSCLC include youth,femininity,EGFR mutations,and concomitant ALK rearrangement mutations.Early identification and intervention of these high-risk factors can help improve the survival rate and quality of life of NSCLC patients with brain me-tastases.

Non-small cell lung cancerHigh-risk factorsBrain metastasisTreatment meth-odsPrognosis

周开甲、周冰、陈泽磊、陈昭芳、陈婷、陈溥、张鸿辉

展开 >

福建医科大学肿瘤临床医学院/福建省肿瘤医院/复旦大学附属肿瘤医院福建医院神经肿瘤外科,福建 福州 350001

福建医科大学基础医学院,福建 福州 350001

福州大学计算机学院,福建 福州 350001

非小细胞肺癌 高危因素 脑转移 治疗方式 预后

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(20)